TKS1
TKS1 is a a life science focused venture capital fund formed by the partnership between SPRIM and Tikehau Capital.
TKS1
Status:
Active
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-05-12 | Travecta Therapeutics | TKS1 investment in Series A - Travecta Therapeutics | 15 M USD |